0000899866-21-000051.txt : 20210716
0000899866-21-000051.hdr.sgml : 20210716
20210716164330
ACCESSION NUMBER: 0000899866-21-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210714
FILED AS OF DATE: 20210716
DATE AS OF CHANGE: 20210716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goff Brian
CENTRAL INDEX KEY: 0001546216
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 211095906
MAIL ADDRESS:
STREET 1: C/O ALEXION PHARMACEUTICALS, INC
STREET 2: 100 COLLEGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 4752302596
MAIL ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960111
4
1
wf-form4_162646819566694.xml
FORM 4
X0306
4
2021-07-14
0
0000899866
ALEXION PHARMACEUTICALS, INC.
ALXN
0001546216
Goff Brian
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BOULEVARD
BOSTON
MA
02210
0
1
0
0
EVP & Chief Commercial Officer
Common Stock, par value $.0001 per share
2021-07-14
4
A
0
30643
0
A
121331
D
Common Stock, par value $.0001 per share
2021-07-14
4
A
0
29501
0
A
150832
D
On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan.
On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan.
/s/ Douglas Barry, Attorney-in-Fact for Brian Goff
2021-07-16